AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models.

Autor: Shaw, Stephen M.^1,2 (AUTHOR), Middleton, Jenny^1,2 (AUTHOR), Wigglesworth, Kim³ (AUTHOR), Charlemagne, Amber¹ (AUTHOR), Schulz, Oliver⁴ (AUTHOR), Glossop, Melanie S.¹ (AUTHOR), Whalen, Giles F.^3,5 (AUTHOR), Old, Robert⁶ (AUTHOR), Westby, Mike¹ (AUTHOR), Pickford, Chris¹ (AUTHOR), Tabakman, Rinat² (AUTHOR), Carmi-Levy, Irit² (AUTHOR), Vainstein, Abi² (AUTHOR), Sorani, Ella² (AUTHOR), Zur, Arik A.² (AUTHOR) arikz@biolinerx.com, Kristian, Sascha A.¹ (AUTHOR)

Publikováno v: Cancer Cell International. 12/19/2019, Vol. 19 Issue 1, p1-19. 19p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A fresh look at China.

Autor: Shaw, Stephen M., Woetzel, Jonathan R.

Publikováno v: McKinsey Quarterly. 1992, Issue 3, p37-51. 15p. 3 Diagrams, 5 Charts, 13 Graphs.

Pro Oracle database 10g RAC on Linux [electronic resource] : installation, administration, and performance / Julian Dyke and Steve Shaw.

Autor: Dyke, Julian

Externí odkaz: Kolekce e-knih KNAV Registrovani uzivatele: plny text online 5 minut, dalsi pristup na vyzadani. Registered users: full text online 5 minutes, further access on request.

Safety Notables: Information from the Literature.

Autor: Brown, Derek B., Ironside, Michael D., Shaw, Stephen M.

Publikováno v: Organic Process Research & Development; Mar2016, Vol. 20 Issue 3, p575-582, 8p